Locanabio

About

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

1 - 10

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $100M
Industries: Biotechnology,Health Care,Therapeutics
Founded date: Jan 1, 2016
Number Of Employee: 1 - 10
Operating Status: Active

Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$155M

Locanabio has raised a total of $155M in funding over 2 rounds. Their latest funding was raised on Dec 14, 2020 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 14, 2020	Series B	$100M	1	—	—	Detail
May 22, 2019	Series A	$55M	1	ARCH Venture Partners	—	Detail

Investments

Number of Investments

Number of Lead Investments

4

0

Locanabio has made 4 investments. Their most recent investment was on Oct 30, 2018, when Coinbase raised $300M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Oct 30, 2018 Coinbase	Series E	$300M	Bitcoin	—
Jul 23, 2018 Algorand	Series Unknown	—	Blockchain	—
Jul 9, 2018 Oasis Labs	Series A	$45M	Blockchain	—
Jun 6, 2018 Arweave	Seed	$8.70M	Blockchain	—